Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-024776
Filing Date
2024-10-04
Accepted
2024-10-04 17:09:38
Documents
1
Period of Report
2024-10-03

Document Format Files

Seq Description Document Type Size
1 form4-10042024_091035.html 4  
1 form4-10042024_091035.xml 4 4106
  Complete submission text file 0001415889-24-024776.txt   5476
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Issuer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 535 BOYLSTON ST., 2ND FLOOR BOSTON MA 02116
Business Address
Namouni Fouad (Reporting) CIK: 0001815851 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37359 | Film No.: 241355601